Optimizing Selective NaV1.8 Inhibition for Burn Pain Without Impairing Wound Healing
- Research team: Principal investigator Taichi Goto, PhD, RN, PHN
- Funding sponsor: Dean’s Research Award
- Overview: This pilot study will evaluate a newly approved non-opioid pain medication, suzetrigine, to determine whether it can relieve burn-associated pain without impairing wound healing.
- Budget: $5,000
- Project period: August 2026, through July 2027
